Muhammad Kashif, PhD^1*, Niki Throumpari^2*, Katarina Uttervall^2,3*, Kristin Roseth Aass^4*, Therese Standal, PhD^4*, Kristine Misund, PhD^4*, Hareth Nahi, MD^2,5*, Robin Mjelle, PhD^4*, Evren Alici, MD² and Johan Lund, MD, PhD^2,3*

¹Department of Medicine, Karolinska Institutet, Huddinge, Sweden
²Department of Medicine, Karolinska Institutet, Stockholm, Sweden
³Hematology Medical Unit, Karolinska University Hospital, Stockholm, Sweden
⁴Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway
⁵Department of Medicine, Södersjukhuset, Stockholm, Sweden

Binod Dhakal, MBBS¹, Michael Slade, MD, MS², Ravi Narra, MD^3*, Mostafa E. Mohamed^4*, Othman S Akhtar, MD¹, Hima Bansal, PhD^5*, Maria Jose Acevedo-Calado, PhD^5*, Oren Pasvolsky, MD^6*, Mahmoud R. Gaballa, MD⁵, Melody R. Becnel, MD⁷, Donna M. Weber, MD⁵, Krina K. Patel, MD, MSc⁸, Sheeba K. Thomas, MD⁷, J Christine Ye, MD^9*, Frank Kuhr^10*, Bamboo Dong^11*, Shemeeakah Powell^10*, Thai Bui^10*, Meera Mohan, MD¹², Marcelo C. Pasquini, MD, MS¹³, Anita D'Souza, MD, MS^1*, Halyna Knysh^10*, Robert Z. Orlowski, MD, PhD⁵, Maher Albitar, MD^14* and Hans C. Lee, MD¹⁵

¹Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²Division of Oncology, Washington University School of Medicine, St. Louis, MO
³BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶MD Anderson Cancer Center, Houston
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸M.D. Anderson Cancer Center, MD Anderson Cancer Center, Houston, TX
⁹Department of Lymphoma & Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁰Menarini Silicon Biosystems, Bryn Athyn
¹¹Menarini Silicon Biosystems, Huntingdon Valley, PA
¹²Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
¹³Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
¹⁴Genomic Testing Cooperative, Lake Forest, CA
¹⁵Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX

Johannes Waldschmidt, MD¹, Maximilian Merz, MD², Judith S. Hecker, MD^3*, Franz Reinhard^4*, Benjamin GT Shibru^2*, Marion Hoegner, MD^5*, Anna Gebauer^4*, David Fandrei, MSc^2*, Manja Meggendorfer, PhD⁶, Marietta Truger^7*, Johannes Jung^8*, Daniel Teschner, MD^1*, Max S. Topp^1*, Anna Purcarea, MD^9*, Vladan Vucinic, MD^10*, Martin K. Kortüm^4*, Torsten Haferlach, MD⁷, Florian Bassermann, MD^11*, Uwe Platzbecker, MD¹², Hermann Einsele, MD⁴, Claudia Haferlach, MD⁷, Klaus H Metzeler, MD², Katharina S. S. Götze, MD³ and Leo Rasche, MD^13*

¹Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
²Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
³Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
⁴Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
⁵Department of Medicine III, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany
⁶MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
⁷MLL Munich Leukemia Laboratory, Munich, Germany
⁸Technical University of Munich (TUM), School of Medicine and Health, Munchen, DEU
⁹Department of Medicine III and Center for Translational Cancer Research, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
¹⁰Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany
¹¹Department of Medicine III, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
¹²Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany
¹³Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany

Mohamed Bikhet, MBBCh^1*, Halimat Olaniyan, MD¹, Wen Niu, MS^2*, Marwan Tayeh, PhD^3*, Francesco Vetrini, PhD^2,4* and Nichole LePage, MD^1*

¹Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN
²Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN
³Indiana University School of Medicine, Undiagnosed Rare Disease Clinic, Indianapolis, IN
⁴Indiana University School of Medicine, Undiagnosed Rare Disease Clinic, Ind, IN

Steven Shih, MBBS¹, Harjot Vohra, MD, CCRP, MLT^1*, Anup Joseph Devasia, MD, DM^1*, Sahar Khan, FRCPath, MB BCh^2*, Eshetu Atenafu, M.Sc, P. Stat^3*, Donna Reece, MD¹, Suzanne Trudel, MD, MSc¹, A. Keith Stewart, MBChB¹, Sita D. Bhella, MD¹, Vishal Kukreti, MD, MSc⁴, Chloe Yang, MD^1*, Rodger E. Tiedemann¹, Anca Prica, MD¹, Eugene Leung, CCPA, BScPA, RT(T)^1* and Christine I Chen, MHPE, MD⁵

¹Princess Margaret Cancer Centre, Toronto, ON, Canada
²Windsor Regional Cancer Centre, Windsor, ON, Canada
³Biostatistics, University Health Network, Toronto, Canada
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Leah Grossman^1,2*, Adolfo Aleman, Jr.^1,3*, Morgan van Kesteren^4,5*, Sidorela Reci, BS^1,3*, Charles Gleason^4,5*, Kseniya Serebryakova^1,3*, Katerina Kappes, BSc^1,3*, Hayley Jackson^1,3*, Jessica Nardulli^4,5*, Hyun Min Kang^4,5*, Jacob Mischka^4,5*, Komal Srivastava^4,5*, Lubbertus CF Mulder^4,5*, Sundar Jagannath, MD¹, Florian Krammer, PhD^4,5*, Viviana Simon, MD, PhD^4,5,6,7,8* and Samir Parekh, MD^1,3

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY
³Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Center for Vaccine Research and Pandemic Preparedness, New York, NY
⁵Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY
⁶The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁷Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
⁸Department of Pathology, Molecular and Cell based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

Ziad Abuhelwa, MD, MPH^1,2, Fnu Amisha, MD^2,3, Wenyi Fan, MSPH^1*, Gabriel De Avila^1*, Doris K. Hansen, MD⁴, Ariel F. Grajales-Cruz, MD¹, Brandon Blue, MD¹, Omar Castaneda, MD⁴, Hien Liu, MD⁵, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP⁴, Taiga Nishihori, MD⁵, Frederick Locke, MD⁵, Kenneth H. Shain, MD, PhD⁶, Rachid Baz, MD⁵ and Melissa Alsina, MD⁵

¹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Morsani College of Medicine, University of South Florida, Tampa, FL
³Department of Hematology and Oncology, USF Morsani/H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Moffitt Cancer Center, Tampa, FL
⁶H. Lee Moffitt Cancer Center, Tampa, FL

Lingling Shu, Ph.D^1*, Ziang Zhu^1*, Yang Li^2*, Hanying Huang^3*, Xiaoqin Chen, MD, PhD^4*, Zhongjun Xia, MD^5* and Yang Liang⁶

¹Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
²Sun Yat-Sen University Cancer Center, Guangzhou, CHN
³Department of Hematologic Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
⁴Department of Hematological Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China
⁵Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁶Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Noemi Puig, PhD¹, Panagiotis Malandrakis, MD^2*, Cristina Agullo^3*, Sergio Castro^4*, Teresa Contreras^3*, Veronica Gonzalez-Calle, MD, PhD^5*, Beatriz Rey-Búa^6*, Borja Puertas Martínez^7*, Evangelos Terpos, MD, PhD², Meletios A. Dimopoulos^{2,8,9,10,11,12,13,14}, Maria- Victoria Mateos^7,15,16,17 and Efstathios Kastritis, MD^2,12,18*

¹Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain, Salamanca, Spain
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Biochemistry Department, University Hospital of Salamanca, Salamanca, ESP
⁴Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
⁵University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Salamanca, ESP
⁶Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain
⁷University Hospital of Salamanca, Salamanca, Spain
⁸Princess Margaret Hospital, Toronto, ON, Canada
⁹Alexandra General Hospital, Athens, Greece
¹⁰General Hospital of Athens-Alexandra, Llisia, Greece
¹¹University of Athens School of Medicine, Athens, Greece
¹²National and Kapodistrian University of Athens, Athens, Greece
¹³Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
¹⁴National and Kapodistrian University of Athens, Alexandra General Hospital, Athens, Greece
¹⁵Hematology Department, IBSAL-University Hospital of Salamanca. University of Salamanca., Salamanca, Spain
¹⁶University of Salamanca, Department of Medicine, Salamanca, Spain
¹⁷Salamanca/Instituto de Investigacio´ n Biome´ dica de Salamanca/Centre for Cancer Research Institute of Cancer Molecular and Cellular Biology, Salamanca, Spain
¹⁸Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Voula,Athens, AL, Greece

Nadine Abdallah, MD¹, Matthew Rees^1*, Supriya Gupta, MD², Mohammed Elhaj^1*, Radhika Bansal, MBBS^3,4*, Terri Menser^5*, Gavin Schaeferle^1*, Joselle Cook, MBBS⁶, Taxiarchis Kourelis, MD², Rahma M Warsame, MD², Wilson I. Gonsalves, MD⁷, Prashant Kapoor, MD¹, Francis Buadi, MD², Suzanne R Hayman, MD², David Dingli, MD, PhD², Morie A. Gertz, MD², Yi Lin, MD, PhD² and Shaji Kumar, MD²

¹Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Bismarck, ND
⁴Internal Medicine, Zucker School of Medicine at Hofstra/Northwell at Lenox Hill, New York, NY
⁵Health Care Delivery Research, Mayo Clinic, Rochester, MN
⁶Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
⁷Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN

Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^*, Charalampos Filippatos^*, Anastasios Ntanasis-Stathopoulos, MD^*, Panagiotis Malandrakis, MD^*, Efstathios Kastritis, MD, PhD^*, Meletios A. Dimopoulos, MD, Evangelos Terpos, MD, PhD and Maria Gavriatopoulou^*

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Alexandra Dreyfuss, MD, MSTR^1*, Beatrice Fregonese, MPH^1*, Saad Z. Usmani, MD², Sham Mailankody, MD, MBBS², Brandon S. Imber, MD, MA¹ and Joachim Yahalom, MD¹

¹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Hee Jeong Cho^1,2*, Myung-Won Lee, MD³, Yunji Lee, M.D.^4*, Jungmin Lee, PhD^5*, Jae Hoon Lee^6*, Hyun-Seok Uhm^7*, Jong Heon Jung^7*, Ho-Young Yhim, MD^8*, Dok Hyun Yoon, MD, PhD⁹, Hyungwoo Cho, MD^10*, Sung-Soo Yoon, M.D., Ph.D.¹¹, Ja Min Byun, MD, PhD¹¹, Young Rok Do, MD, PhD¹², Hyo Jung Kim, MD, PhD^13*, Ji Hyun Lee, MD, PhD¹⁴, Sung-Nam Lim, MD^15*, Hye Jin Kang^16*, Ho Sup Lee, MD, PhD^17*, Yundeok Kim, MD^18*, Hee jeong Lee^19*, Sang Min Lee, MD^20*, Joon Ho Moon, MD²¹ and Kihyun Kim, MD, PhD²²

¹Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea, Republic of (South)
²Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
³Department of Internal Medicine, College of Medicine, Chungnam National University, Sejong, Korea, Republic of (South)
⁴Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
⁵Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, KOR
⁶Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
⁷National Cancer Center, Goyang, Korea, Republic of (South)
⁸Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea, Republic of (South)
⁹Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
¹⁰Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
¹¹Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹²Department of Hemato-Oncology, Dongsan Medical Center, Keimyung University, Daegu, Korea, Republic of (South)
¹³Hallym University Sacred Heart Hospital, Anyang-Si, Korea, Republic of (South)
¹⁴Dong-A University College of Medicine, Busan, South Korea
¹⁵Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea, Republic of (South)
¹⁶Korea Cancer Center Hospital, Seoul, KOR
¹⁷Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea, Republic of (South)
¹⁸Wonju Severance Christian Hospital, Wonju, KOR
¹⁹Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, Korea, Republic of (South)
²⁰Inje University Busan Paik Hospital, Busangingu, Busan, KOR
²¹Department of Hematology, Kyungpook National Univ. Hospital, Daegu, Korea, Republic of (South)
²²Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Enrica Antonia Martino, MD^1*, Daniele Derudas^2*, Elena Rossi, MD^3*, Sofia Terlizzi^4*, Giovanni Reddiconto^5*, Paola Stefanoni^6*, Jacopo Micozzi, MD^7*, Silvia Mangiacavalli, MD^8*, Elena Zamagni, MD^9*, Massimo Offidani, MD ^10*, Anna Furlan, MD^11*, Gabriele Buda Sr.¹², Flavia Lotti, MD^13*, Carmine Liberatore^14*, Antonio Lazzaro^15*, Roberta Della Pepa, MD^16*, Giuseppe Bertuglia^17*, Emiliano Barbieri^18*, Concetta Conticello, MD^19*, Claudio De Magistris^20*, Lorenzo De Paoli^21*, Velia Bongarzoni^22*, Anna Maria Cafro, MD^23*, Anna Mele, MD^24*, Pietro Benvenuti^25*, Claudio Cerchione, MD²⁶, Cirino Botta, MD, PhD^27*, Elisabetta Antonioli^28*, Nicola Sgherza^29*, Sara Aquino, MD, PhD^30*, Giuseppe Mele^31*, Gregorio Barila^32*, Salvatore Palmieri^33*, Ombretta Annibali, MD^34*, Rosario Bianco, MD^35*, Massimiliano Arangio Febbo, MD^36*, Gloria Margiotta Casaluci, MD^37*, Angela Rago^38*, Raffaele Fontana, MD^39*, Francesca Farina^40*, Ernesto Vigna, MD^41*, Antonella Bruzzese^42*, Catello Califano, MD^43*, Angela Amendola^44*, Daniela Roccotelli, MD^45*, Alessandra Lombardo, MD^46*, Annalisa Citro^47*, Giuseppina Uccello^48*, Renato Zambello^49*, Alessandro Maggi, MD^50*, Santo Neri^51*, Michele Monachesi^52*, Alessandro Gozzetti^53*, Vittorio Montefusco, MD^54*, Marino Brunori^55*, Nicola Di Renzo^56*, Marta Coscia, MD, PhD^57*, Valerio De Stefano, MD^3*, Antonino Neri, MD^58*, Francesco Di Raimondo, MD, Prof⁵⁹, Fortunato Morabito^60*, Pellegrino Musto^61,62* and Massimo Gentile, MD^63,64*

¹Department of Onco-Hematology, Hematology Unit AO of Cosenza, Cosenza, Italy
²Department of Hematology, Struttura Complessa di Ematologia e Centro Trapianto Cellule Staminali Emopoieti, Cagliari, Italy
³Fondazione Policlinico Gemelli IRCCS, Section of Hematology, Catholic University, Rome, Roma, Italy
⁴Department of Hematology, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy
⁵Haematology, Ospedale V. Fazzi, Lecce, Italy, Lecce, ITA
⁶Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
⁷Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
⁸Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁹IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", and Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy
¹⁰Clinica di Ematologia Ospedali Riuniti Ancona, Ancona, Italy
¹¹Divisione di Ematologia, Ospedale Cà Foncello di Treviso-ASL 2, Treviso, Italy
¹²university of pisa, Pisa, PI, Italy
¹³Sezione di Ematologia e Immunologia Clinica, Ospedale Santa Maria della Misericordia, località Sant’Andrea delle Fratte, Perugia, Italy
¹⁴Hematology Unit, Department of Oncology and Hematology,, Ospedale Santo Spirito, Pescara, ITA
¹⁵Division of Hematology and Bone Marrow Transplant Center, Hospital Guglielmo da Saliceto, PIACENZA PC, ITA
¹⁶Department of Clinical Medicine and Surgery, AOU Federico II, Naples, Italy
¹⁷Myeloma Unit, Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
¹⁸Hematology Unit, Arcispedale S. Maria Nuova, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy
¹⁹AOU Policlinico G. Rodolico-San Marco, University School of Medicine, Catania, Italy, Catania, ITA
²⁰Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, milan, Italy
²¹Division of Hematology, Ospedale Sant’Andrea, Vercelli, Italy
²²Department of Hematology, San Giovanni-Addolorata Hospital, ROMA, ITA
²³Department of Hematology, GOM Niguarda Hospital, Milan, Milan, ITA
²⁴Hematology Unit, Azienda C. Panico, Tricase, Italy
²⁵Department of Medicine and Surgery, University of Insubria and Department of Oncology, ASST Sette Laghi, Ospedale di Circolo, Varese, ITA
²⁶Hematology Unit, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS, Meldola (FC), Italy
²⁷University of Palermo, Palermo, ITA
²⁸Careggi Hospital and University of Florence, Firenze, Italy
²⁹Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico Bari, Bari, Italy
³⁰Ematologia e Terapie cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy
³¹Haematology and Stem Cell Transplant Unit, Ospedale Antonio Perrino, Brindisi, AL, Italy
³²Hematology Unit, Ospedale San Bortolo, Vicenza, Italy
³³Ospedale A. Cardarelli, Napoli, Italy, Napoli, Italy
³⁴Division of Hematology, Stem Cell Transplantation,, Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italy
³⁵UOC Ematologia, AORN Sant’Anna e San Sebastiano di Caserta, Caserta, ITA
³⁶Onco Hematology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy
³⁷Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
³⁸UOSD Ematologia, ASL Roma 1, Roma, Italy
³⁹Hematology and Transplant Center, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Salerno, Italy
⁴⁰Hematology and BMT unit, IRCCS Ospedale San Raffaele, Milano, Italy
⁴¹U.O. Di Ematologia, Ospedale L'Annunziata, Cosenza, ITA
⁴²Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, COSENZA, Italy
⁴³EMATOLOGIA, ASL SALERNO, PRESIDIO OSPEDALIERO TORTORA PAGANI, Pagani, ITA
⁴⁴Ematologia, AOR San Carlo, Potenza, Potenza, ITA
⁴⁵Department of Hematology and Bone Marrow Transplant, IRCSS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy
⁴⁶S.C. di Oncoematologia, A.O. Santa Maria di Terni, Terni, Italy
⁴⁷UOC Ematologia, Ospedale Civile di Legnano, Legnano, Italy
⁴⁸Hematology Unit, Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) Garibaldi, Catania, Italy
⁴⁹Department of Medicine, Hematology and Clinical Immunology section, Padua University School of Medicine, Padova, Italy
⁵⁰Division of Hematology and Bone Marrow Transplant, Ospedale S.G. Moscati, Taranto, Italy
⁵¹Hematology Unit, Azienda Ospedaliera Papardo, Messina, IT-ME, ITA
⁵²Institute of Hematology, Perugia University and IbiT Foundation, Perugia, Italy
⁵³Division of Hematology, University of Siena, Siena, Italy
⁵⁴Hematology, ASST Santi Paolo e Carlo, Milan, Italy
⁵⁵Ematologia Ospedale Santa Croce Fano, Fano, Italy
⁵⁶"Vito Fazzi" Hospital, Hematology and Stem Cell Transplant Unit, Lecce, Italy
⁵⁷Hematology Division, ASST Sette Laghi, Ospedale di Circolo, Varese, Italy
⁵⁸Scientific Directorate, Azienda Unità Sanitaria Locale-IRCCS Reggio Emilia, Reggio Emilia, Reggio Emilia, Italy
⁵⁹Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Catania, Italy, Catania, Italy
⁶⁰Gruppo Amici Dell'Ematologia Foundation-GrADE, Reggio Emilia, Italy
⁶¹Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy
⁶²Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine,and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Bari, Italy
⁶³Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy, Cosenza, Italy
⁶⁴Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy

Jing Li, MD^1*, Yang Yang, MD^1*, Chenqi Yu, MD^1*, Yuxia Yang^2* and Peng Liu, MD^1,3

¹Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China
²Yikon Genomics, Suzhou, China
³Department of Hematology, Shanghai Geriatric Medical Center, Shanghai, China

Marina Hajiyianni^1*, Christos Sachpekidis, MD^2*, Annette Kopp-Schneider, PhD^3*, Elias Karl Mai, MD^1*, Sandra Sauer, MD^1*, Ekaterina Menis, PhD^1*, Michael Hundemer, MD^4*, Niels Weinhold, PhD⁵, Jens Hillengass, MD, PhD⁶, Marc-Steffen Raab, MD^1*, Antonia Dimitrakopoulou-Strauss, MD^2* and Hartmut Goldschmidt, MD¹

¹Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
²Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
³Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
⁴Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
⁵Heidelberg Myeloma Center, Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁶Department of Medicine - Myeloma, Roswell Park, Buffalo, NY

Cindy Varga, MD, BSc¹, Myra Robinson^2*, Vikas Gupta^3*, Craig C. Hofmeister, MD⁴, Ajay K. Nooka, MD, MPH⁵, Jonathan L. Kaufman, MD⁴, Madhav V. Dhodapkar, MD PhD⁴, Sagar Lonial, MD^4*, Shanice Borden^6*, Christopher Ferreri⁷, Barry Paul, MD, MS⁷, Shebli Atrash, MD, MS⁷, Manisha Bhutani, MD⁸, Peter M. Voorhees, MD⁹ and Nisha S. Joseph, MD⁴

¹Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Matthews, NC
²Department of Biostatistics and Data Sciences, Levine Cancer Institute, Charlotte, NC
³Emory Winship Cancer Institute, Atlanta
⁴Winship Cancer Institute of Emory University, Atlanta, GA
⁵Winship Cancer Institute Suite 5010, Atlanta, GA
⁶Levine Cancer Institute, Atrium Health, Charlotte, NC
⁷Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁸Atrium Health Levin Cancer Institute, Charlotte, NC
⁹Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC

Chenya Zhao, MS^1*, Loic Le Marchand^2*, Lynne Wilkens^2*, Howard Hu^3*, Christopher Haiman^3* and Wendy Cozen, DO, MPH⁴

¹Department of Population and Health Sciences, University of Southern California, Alhambra, CA
²University of Hawai'i Cancer Center, University of Hawai'i, Honolulu, HI
³Department of Population and Health Sciences, University of Southern California, Los Angeles, CA
⁴Division of Hematology-Oncology, Department of Medicine, UCI, School of Medicine, Orange, CA

Saurabh Zanwar, MD, MBBS¹, Dragan Jevremovic, M.D., Ph.D^2*, Prashant Kapoor, MD², Horatiu Olteanu, M.D., Ph.D.³, Francis Buadi, MD¹, Pedro Horna, MD³, Wilson I. Gonsalves, MD⁴, Gregory Otteson^5*, Suzanne R Hayman, MD⁶, Nadine Abdallah, MD², Moritz Binder, MD¹, Joselle Cook, MBBS⁶, Angela Dispenzieri, MD¹, David Dingli, MD, PhD¹, Morie A. Gertz, MD⁶, Taxiarchis Kourelis, MD¹, Nelson Leung, MD⁷, Yi Lin, MD, PhD¹, Eli Muchtar, MD¹, Rahma M Warsame, MD¹, Amie Fonder, PA-C, MS^8*, Miriam Hobbs, APRN, CNP, DNP^1*, Yi Lisa Hwa, APRN, DNP, CNP¹, Michelle G. Rogers, CNP^1*, Robert A. Kyle, MD¹, Vincent Rajkumar, MD^1* and Shaji Kumar, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Mayo Clinic, Rochester, MN
³Division of Hematopathology, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
⁵Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁶Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
⁷Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁸Hematology, Mayo Clinic, Rochester, MN

Xiang Zhou, MD, BMBS¹, Sarah Wiethe^2*, Angelika Wolff^2*, Max J Steinhardt^3*, Nazia Afrin^4*, Mara John^5*, Christine Riedhammer, MD^6*, Xianghui Xiao, MD^7*, Umair Munawar^8*, Julia Mersi, MD^9*, Seungbin Han, MSc^10*, Johannes Waldschmidt, MD^3,11,12, Angela Riedel, PhD^5*, Max S. Topp^13*, Johannes Duell, MD^14*, Hermann Einsele, MD³, K. Martin Kortüm, MD^15* and Leo Rasche, MD^16*

¹University Hospital Wuerzburg, Wurzburg, Germany
²University Hospital Wurzburg, Wurzburg, Germany
³Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
⁴Mildred Scheel Early Career Center for Cancer Research, University Hospital Wuerzburg, Wuerzburg, Germany
⁵Mildred Scheel Early Career Center for Cancer Research, University Hospital Wurzburg, Wurzburg, Germany
⁶Department of Internal Medicine II, University of Regensburg, Regensburg, Germany
⁷Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
⁸University Hospital of Wuerzburg, Wuerzburg, Germany
⁹Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
¹⁰University of Wurzburg, Wuerzburg, DEU
¹¹Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
¹²Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Baden Wurttemberg, Germany
¹³University Hospital Wuerzburg, Wuerzburg, Germany
¹⁴University of Wurzburg, Wurzburg, Germany
¹⁵Department of Internal Medicine II, University Hospital of Würzburg, Wuerzburg, Germany
¹⁶Department of Internal Medicine, University Hospital of Würzburg, Würzburg, Germany

Rabia Iqbal^1*, Ahmad Taimoor Bajwa^2*, Aemen Shafqat Bazaz^3*, Mrunanjali Gaddam, MD^1*, Fiqe Khan^4*, Nyan Linn Htet^4*, Aqsa Mumtaz, MD, MBBS^5* and Faiz Anwer, MD⁶

¹Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY
²The Brooklyn Hospital Center, brooklyn, NY
³Rawalpindi Medical University, Rawalpindi, Pakistan
⁴The Brooklyn Hospital Center, Brooklyn
⁵Montefiore St. Luke's Cornwall, Newburgh, NY
⁶Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Ja Min Byun, MD, PhD¹, Sung-Soo Park, MD, PhD^2*, Suein Choi^3*, Youngil Koh, MD, PhD¹, Chang-Ki Min^4* and Seunghoon Han^5*

¹Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
²Division of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
³The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁴Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁵Department of Pharmacology, College of Medicine, The Catholic University of Kore, Seoul, KOR

Utkarsh Goel, MBBS¹, Danai Dima, MD^2,3, James A Davis, PharmD^4*, Aliya Rashid, DO, MPH⁵, William Wesson, MD, MPH⁶, Shaun DeJarnette^7*, Fauzia Ullah, MD^8*, Evguenia Ouchveridze, MD⁷, Mariam Markouli, MD^9*, Claire Yun Kyoung Ryu Tiger, MD^10*, Louis Williams, MD⁸, Sandra Mazzoni, DO^2*, Beth M. Faiman, PhD, CNP⁸, Craig Sauter, MD^11*, Faiz Anwer, MD², Shahzad Raza, MD², Leyla O. Shune, MD⁷ and Jack Khouri, MD⁸

¹Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
²Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
³University of Washington, Seattle, WA
⁴Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS
⁶School of Medicine, University of Kansas Medical Center, Kansas City, KS
⁷University of Kansas Medical Center, Kansas City, KS
⁸Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁹Boston University Medical Center, Boston
¹⁰Rutgers Cancer Institute, New Brunswick, NJ
¹¹Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Yuntong Liu^1*, Lu-Gui Qiu, MD² and Gang An^3*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, UT, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Xiaozhe Li^1* and Juan Li, PhD²

¹The first affliated of sun yat-sen university, Guangzhou, China
²The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

Jacob T Shreve, MD¹, Michael D Howe^2*, Emmanuel Contreras Guzman^1*, Charalampos Charalampous^1*, Wilson I. Gonsalves, MD¹, Francis Buadi, MD¹, Taxiarchis Kourelis, MD¹, Suzanne R Hayman, MD¹, Morie A. Gertz, MD¹, Rafael Fonseca, MD¹, S. Vincent Rajkumar, MD^1*, Surendra Dasari, PhD^3*, Matthew P. Thorpe^4*, Stephen Broski^4*, Shaji Kumar, MD¹ and Moritz Binder, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
³Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁴Department of Radiology, Mayo Clinic, Rochester, MN

Cindy Varga, MD^1*, Myra Robinson^2*, James Davis, MD^3*, Hamza Sloan Hashmi, MD^4*, Thomas Martin, MD⁵, Anupama Deepa Kumar, MD⁶, Douglas W Sborov, MD⁷, Charlotte B Wagner, PharmD^8*, Doris K. Hansen, MD⁹, Omar Castaneda, MD⁹, Leyla O. Shune, MD¹⁰, Shaun DeJarnette^10*, Aimaz Afrough, MD¹¹, Larry D Anderson Jr., MD, PhD¹², Binod Dhakal, MBBS¹³, Kinaya Smith, MD^14*, Megan M Herr, PhD¹⁵, Shambavi Richard, MD¹⁶, Alex Lieberman-Cribbin^16*, Daniel W. Sherbenou, MD, PhD¹⁷, Peter A. Forsberg, MD¹⁸ and Peter M. Voorhees, MD¹⁹

¹Department of Hematologic Oncology & Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
²Department of Biostatistics and Data Sciences, Levine Cancer Institute, Charlotte, NC
³Department of Hematology-Oncology, The Medical University of South Carolina (MUSC), Charleston, SC
⁴Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
⁵Department of Hematology, University of California at San Francisco, San Francisco, CA
⁶University of California, San Francisco, San Francisco, CA
⁷Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁸Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
⁹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁰University of Kansas Medical Center, Kansas City, KS
¹¹Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Coppell, TX
¹²Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
¹³Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹⁴Medical College of Wisconsin, Milwaukee, WI
¹⁵Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹⁶Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁷Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
¹⁸University of Colorado School of Medicine, Aurora, CO
¹⁹Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC

Sharmilan Thanendrarajan, MD¹, Phil Farmer^2*, Clyde Bailey, BS^1*, Carolina Schinke, MD¹, Samer Al Hadidi, MD, MSc³, Maurizio Zangari, MD¹, Stephanie Rogers, MNSc, APRN, AGPNP-BC^1*, Anne Williams, APRN, MNSc, FNP-C^1*, Fenghuang Zhan, MD¹, John D Shaughnessy, Jr, PhD^4*, Tanvi H. Patel, MD^1*, Anup Kumar Trikannad, MD⁵, Asis Shrestha, MD^1*, Syed Naqvi, MD^2*, Hira Imad Cheema, MD^1*, Trilok Shrivastava, MD^1*, Manozna Karri, MD^1*, Ramya Bachu, MD^1* and Frits van Rhee, MD, PhD¹

¹Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
²Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR
³University of Arkansas for Medical Sciences, Little Rock, AR
⁴Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical sciences, Little Rock, AR
⁵Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, LITTLE ROCK, AR

Johannes Waldschmidt, MD¹, Mark Kidd, PhD^2*, Sophia Danhof^3*, Martin Schreder, MD^4*, Ignat Drozdov^2*, Cornelia Vogt^1*, Hermann Einsele, MD³, Leo Rasche, MD^5*, Abdel Halim^2* and Martin K. Kortüm^3*

¹Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
²Wren Laboratories, Branford, CT
³Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
⁴First Department of Medicine, Klinik Ottakring, Vienna, Austria
⁵Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany

Maria Gavriatopoulou^1*, Vassilis Koutoulidis^2*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^1*, Panagiotis Malandrakis, MD^1*, Maria Douka^2*, Vasiliki Spiliopoulou, MD^1*, Charalampos Filippatos^1*, Despina Fotiou, MD^1*, Magdalini Migkou, MD^1*, Nikolaos Kanellias^1*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Efstathios Kastritis, MD^1*, Evangelos Terpos, MD, PhD¹, Meletios A. Dimopoulos¹ and Lia-Angela Moulopoulos^2*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²1st Department of Radiology, School of Medicine, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece

Abiola Bolarinwa, MBBS, FMCPath^1*, Saurabh Zanwar, MD, MBBS¹, Nadine Abdallah, MD², Sukriti Seth^1*, Francis Buadi, MD¹, Suzanne R Hayman, MD¹, Morie A. Gertz, MD¹, Angela Dispenzieri, MD¹, Eli Muchtar, MD¹, Prashant Kapoor, MD², Wilson I. Gonsalves, MD³, Taxiarchis Kourelis, MD¹, David Dingli, MD, PhD¹, Rahma M Warsame, MD¹, Nelson Leung, MD¹, Joselle Cook, MBBS¹, Moritz Binder, MD¹, Yi Lin, MD, PhD¹, Yi Lisa Hwa, APRN, DNP, CNP¹, Michelle G. Rogers, CNP^1*, Miriam Hobbs, APRN, CNP, DNP^1*, Amie Fonder, PA-C, MS^1*, Dragan Jevremovic, M.D., Ph.D^4*, S. Vincent Rajkumar, MD¹ and Shaji Kumar, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
⁴Division of Hematopathology, Mayo Clinic, Rochester, MN

Charles Pei^1*, Lisa Blackburn^2*, Nidhi Sharma, PhD^3*, Naresh Bumma, MD⁴, Abdullah Mohammad Khan, MD, MBBS⁵, Srinivas Devarakonda, MD⁶, Elvira Umyarova, MD⁷, Don Benson, MD⁸, Ashley Rosko, MD⁹, Zeinab El Boghdadly, MD^10* and Francesca Cottini, MD⁹

¹The Ohio State University, College of Medicine, Columbus, OH
²The Ohio State University, College of Medicine, Columbus
³Division of Hematology, Ohio State University Medical Center, Columbus, OH
⁴The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
⁵Division of Hematology, The Ohio State University, Columbus, OH
⁶Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁷Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁸Ohio State University Medical Center, Columbus, OH
⁹The Ohio State University, Columbus, OH
¹⁰Division of Infectious Diseases, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH

Carlos Costa, MD^1*, Adriana Isabel Roque, MD, BSc^2,3*, João Santinha, PhD^4*, Manuel Neves, MD^5*, Ana Bela Sarmento-Ribeiro, MD, PhD^2,6,7,8,9*, Rita Gerivaz, MD^10*, Ana Luisa Tomé, MD^11*, Helena Martins, MD^12*, Joana Vieira, MD^12*, Sofia Afonso, MD^13,14*, Joana Santos, MD^10*, Celina Afonso, MD^15*, Ana Jorge, MD^15*, José Freitas, MD^16*, Inês Ramos, MD^17*, Patrícia Sousa, MD^13,18*, Paula César, MD^18*, Teresa Garrido, MD^18*, Dina Rochate, MD^19*, Maria Pedro Silveira, MD^20,21*, Fernanda Trigo Miranda, MD^22,23*, Rui Bergantim, MD^22,23,24,25*, Catarina Geraldes Santos, MD, PhD^2,6,7,8,9* and Cristina Joao, MD, MSc, PhD^5,26,27*

¹Hematology Unit, Hospital CUF Tejo, Lisboa, Lisbon, Portugal
²Clinical Hematolology Unit, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal
³Institute of Physiology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
⁴Digital Surgery Lab, Champalimaud Foundation, Lisbon, Portugal
⁵Hemato-Oncology Unit, Champalimaud Foundation, Lisbon, Portugal
⁶University Clinics of Hematology and Oncology and Laboratory of Oncobiology and Hematology (LOH), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
⁷Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal
⁸Coimbra Institute for Clinical and Biomedical Research (iCBR)—Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
⁹Clinical Academic Center of Coimbra (CACC), University of Coimbra, Coimbra, Portugal
¹⁰Clinical Hematolology Unit, Hospital Santo António dos Capuchos, Unidade Local de Saúde São José, Lisbon, Portugal
¹¹Clinical Hematolology Unit, Hospital Garcia da Orta, Unidade Local de Saúde de Almada-Seixal, Almada, Portugal
¹²Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde de Santa Maria, Lisboa, Portugal
¹³Serviço de Hematologia Clínica, Hospital Pêro da Covilhã, Unidade Local de Saúde da Cova da Beira, Covilhã, Portugal
¹⁴Faculdade de Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal
¹⁵Clinical Hematolology Unit, Hospital de São Francisco Xavier, Unidade Local de Saúde de Lisboa Ocidental, Lisbon, Portugal
¹⁶Serviço de Hematologia, Hospital de Braga, Unidade Local de Saúde de Braga, Porto, Portugal
¹⁷Serviço Onco-Hematologia, Instituto Português Oncologia Porto, Porto, Portugal
¹⁸Hematology Department, Instituto Português Oncologia de Coimbra Francisco Gentil, Coimbra, Portugal
¹⁹Serviço de Hematologia, Hospital do Divino Espírito Santo de Ponta Delgada, Ponta Delgada, Portugal
²⁰Serviço de Imuno-Hemoterapia, Hospital Professor Doutor Fernando Fonseca, Unidade Local de Saúde de Amadora/Sintra, Amadora, Portugal
²¹Hematologia Clínica, Clínica de Oncologia e Radioterapia, [formerly at] Centro Clínico SAMS, Lisboa, Portugal
²²Clinical Hematology Unit, Hospital de São João, Unidade Local de Saúde São João, Porto, Portugal
²³Clinical Hematology, Faculty of Medicine, University of Porto, Porto, Portugal
²⁴i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal
²⁵Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
²⁶Myeloma Lymphoma Research Group, Champalimaud Foundation, Lisboa, Portugal
²⁷NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal

Remy Lee, MD^1*, Shahram Arsang-Jang, PhD^1*, Anita D'Souza, MD¹, Binod Dhakal, MBBS¹, Siegfried Janz, MD, DSc² and Jing Dong, PhD³

¹Medical College of Wisconsin, Milwaukee, WI
²Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
³Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI

Cindy Varga, MD, BSc¹, Ferdous Ahmed, PhD^2*, Marvin Knight^3*, Manisha Bhutani, MD⁴, Barry Paul, MD, MS⁵, Shebli Atrash, MD, MS⁵, Peter M. Voorhees, MD⁶ and Christopher Ferreri⁵

¹Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²levine cancer institute, Charlotte
³Atrium Health Carolina Medical Center, Charlotte
⁴Atrium Health Levin Cancer Institute, Charlotte, NC
⁵Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁶Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC

Rahul Banerjee, MD, FACP¹, Ken Hasegawa, PhD^2*, Taha Itani, PhD, MPH, MBA^2*, Monique Giordana, PharmD, BCOP^2*, Enrique Granados, MD^2*, Margrit B Rosado, PharmD^3*, Rebecca J Chan, MD, PhD^3*, Ana Kostic, MD^3*, Steve Kanters, PhD^4*, Michael J Zoratti, PhD^4* and Xavier Leleu⁵

¹Fred Hutchinson Cancer Center, Seattle, WA
²Kite, A Gilead Company, Santa Monica, CA
³Arcellx, Inc., Redwood City, CA
⁴RainCity Analytics, Vancouver, BC, Canada
⁵Centre Hospitalier Universitaire de Poitiers, Poitiers, France

Adam Sciambi, PhD^1*, Daniel Mendoza, PhD^1*, Indira Krishnan, PhD^1*, Joanne Nguyen^1*, Lubna Nousheen, M.S.^2*, Benjamin Geller, MSc^3*, Cedric Dos Santos, PhD⁴, Vivek S. Chopra^4*, Habib Hamidi, MPH, PhD^4*, Michael Nixon^5*, Yann Nouet, PhD MSc⁶, Todd E. Druley, MD, PhD⁷ and Herve Avet-Loiseau, MD, PhD^8*

¹Mission Bio, South San Francisco, CA
²Mission Bio, SOUTH SAN FRANCISCO, CA
³R&D, Mission Bio, South San Francisco, CA
⁴Genentech, Inc., South San Francisco, CA
⁵Roche, Indianapolis, IN
⁶F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁷Mission Bio, Saint Louis, MO
⁸Institut universitaire du cancer de Toulouse Oncopole, Toulouse, France

Firas Baidoun, MD^1*, Ricardo D. Parrondo, MD¹, Vivek Roy, MD¹, Andre Fernandez, P.A. -C^1*, Caitlin Flott^1*, Taimur Sher, MD^2*, Rami Manochakian, MD^1*, Asher A. Chanan-Khan, MD¹ and Sikander Ailawadhi¹

¹Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
²Division of Hematology, Mayo Clinic, Jacksonville, FL

Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^1*, Maria Douka^2*, Vassilis Koutoulidis^2*, Maria Gavriatopoulou^1*, Panagiotis Malandrakis, MD^1*, Vasiliki Spiliopoulou, MD^1*, Foteini Theodorakakou, MD^1*, Despina Fotiou, MD^1*, Magdalini Migkou, MD^1*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Irene Solia, MD^1*, Nikolaos Kanellias^1*, Efstathios Kastritis, MD^1*, Meletios Dimopoulos, MD¹, Evangelos Terpos, MD, PhD¹ and Lia-Angela Moulopoulos^2*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²1st Department of Radiology, School of Medicine, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece

Claudio Cerchione, MD¹, Alice Rossi, M.D.^2*, Paola Caroli, M.D.^3*, Matteo Marchesini, PhD^1*, Federica Matteucci^4*, Delia Cangini, M.D.^1*, Domenico Barone^4*, Davide Nappi, M.D.^1*, Davide Bezzi^3*, Anna Sarnelli, PhD^3*, Giovanni Martinelli, M.D.⁵, Nicola Normanno, M.D.^1* and Giacomo Feliciani, Ph.D.^1*

¹IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC), Italy
²IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola (FC), Italy
³IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori dino Amadori IRST, Meldola, Meldola, Italy
⁴Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS, Meldola (FC), Italy
⁵Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy

Nishanth Thalambedu, MD¹, Jeffery Sawyer, PhD^2*, Janet L Lukacs^3*, Phil Farmer^4*, Samer Al-Hadidi, MD^5*, Carolina Schinke, MD⁶, Sharmilan Thanendrarajan, MD⁵, Frits van Rhee, MD, PhD⁶ and Maurizio Zangari, MD⁶

¹UAMS, Little Rock, AR
²University of Arkansas For Medical Sciences, Little Rock, AR
³UAMS, Littlerock, AR
⁴Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR
⁵University of Arkansas for Medical Sciences, Little Rock, AR
⁶Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR

Tongyong Yu, MD^1* and Juan Li, PhD²

¹The first affilated hospital of sun yat-sen university, Guangzhou, AL, CHN
²The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

Abiola Bolarinwa, MBBS, FMCPath^1*, Madhu Nagaraj, MD^1*, Saurabh Zanwar, MD, MBBS¹, Nadine Abdallah, MD², P. Leif Bergsagel, MD³, Moritz Binder, MD¹, Francis Buadi, MD¹, Saurabh Chhabra, MD⁴, Joselle Cook, MBBS¹, David Dingli, MD, PhD¹, Angela Dispenzieri, MD¹, Morie A. Gertz, MD¹, Wilson I. Gonsalves, MD⁵, Suzanne R Hayman, MD¹, Prashant Kapoor, MD², Taxiarchis Kourelis, MD¹, Nelson Leung, MD¹, Yi Lin, MD, PhD¹, Eli Muchtar, MD¹, Ricardo D. Parrondo, MD⁶, Vivek Roy, MD⁶, Taimur Sher, MD^7*, Mustaqeem A. Siddiqui, MD, MBA¹, Rahma M Warsame, MD¹, Amie Fonder, PA-C, MS^1*, Miriam Hobbs, APRN, CNP, DNP^1*, Yi Lisa Hwa, APRN, DNP, CNP¹, Michelle G. Rogers, CNP^1*, Udit Yadav, MBBS^8*, J E Wiedmeier-Nutor, MD, MPH⁸, Dragan Jevremovic, M.D., Ph.D^9*, Linda B. Baughn, PhD¹⁰, Vincent Rajkumar, MD^1*, Rafael Fonseca, MD³, Sikander Ailawadhi⁶ and Shaji Kumar, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Mayo Clinic, Rochester, MN
³Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
⁴Division of Hematology, Mayo Clinic, Phoenix, AZ
⁵Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
⁶Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
⁷Division of Hematology, Mayo Clinic, Jacksonville, FL
⁸Division of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, AZ
⁹Division of Hematopathology, Mayo Clinic, Rochester, MN
¹⁰Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Yan Cheng^1*, Fumou Sun, PhD^1*, Daisy V. Alapat, MD², Visanu Wanchai, PhD^3*, David E. Mery, PhD¹, Eric Siegel^4*, Hongwei Xu, DDS^1*, Sarah K. Johnson, PhD^1*, Wancheng Guo, MD^1*, Clyde Bailey, BS^1*, Cody Ashby, PhD^3*, Michael Anton Bauer^3*, Samer Al Hadidi, MD, MSc⁵, Carolina Schinke, MD¹, Sharmilan Thanendrarajan, MD¹, Maurizio Zangari, MD¹, Frits van Rhee, MD, PhD¹, Guido Tricot, MD^1*, John D Shaughnessy, Jr, PhD^1* and Fenghuang Zhan, MD¹

¹Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
²Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
³Department of Bioinformatics, University of Arkansas for Medical Sciences, Little Rock, AR
⁴Department of Biostatistics, University of Arkansas For Medical Sciences, Little Rock, AR
⁵University of Arkansas for Medical Sciences, Little Rock, AR